| Trade name of the product: |
| Kinlytic |
| Pharmaceutical active ingredients: |
| Urokinase |
| Available forms, composition and doses of Kinlytic: |
| Injectable; Injection; Urokinase 250,000 IUInjectable; Injection; Urokinase 5,000 IUInjectable; Injection; Urokinase 9,000 IU |
| Medical categories: |
| Human:Anticoagulants, antiplatelets and fibrinolytics (thrombolytics)Thrombolytic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B01AD04 - Urokinase |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| ImaRx TherapeuticsMicrobix Biosystems |
| Related documents and information about Kinlytic: |
| Kinlytic prescribing information (PDF) |